IQVIA Holdings Inc. (NYSE:IQV) Shares Purchased by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 213.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,929 shares of the medical research company’s stock after buying an additional 2,677 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in IQVIA were worth $994,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the business. AdvisorNet Financial Inc raised its position in IQVIA by 327.6% in the fourth quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock valued at $29,000 after purchasing an additional 95 shares during the period. Rise Advisors LLC purchased a new stake in shares of IQVIA during the 1st quarter valued at about $31,000. Riverview Trust Co acquired a new position in IQVIA during the 1st quarter worth approximately $32,000. Activest Wealth Management purchased a new position in IQVIA in the 4th quarter worth approximately $35,000. Finally, Covestor Ltd grew its position in IQVIA by 45.3% in the first quarter. Covestor Ltd now owns 154 shares of the medical research company’s stock valued at $39,000 after acquiring an additional 48 shares in the last quarter. Hedge funds and other institutional investors own 89.62% of the company’s stock.

IQVIA Price Performance

Shares of IQV traded down $6.46 during trading hours on Thursday, hitting $232.29. The stock had a trading volume of 1,965,594 shares, compared to its average volume of 1,090,432. IQVIA Holdings Inc. has a 52 week low of $167.42 and a 52 week high of $261.73. The stock has a market capitalization of $42.35 billion, a price-to-earnings ratio of 31.85, a P/E/G ratio of 2.19 and a beta of 1.49. The company’s fifty day moving average is $220.12 and its two-hundred day moving average is $229.28. The company has a debt-to-equity ratio of 1.80, a current ratio of 0.85 and a quick ratio of 0.88.

IQVIA (NYSE:IQV) last posted its quarterly earnings data on Monday, July 22nd. The medical research company reported $2.64 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.07. The company had revenue of $3.81 billion during the quarter, compared to analyst estimates of $3.79 billion. IQVIA had a net margin of 9.39% and a return on equity of 28.59%. The company’s revenue was up 2.3% on a year-over-year basis. During the same quarter last year, the business posted $2.22 earnings per share. On average, analysts anticipate that IQVIA Holdings Inc. will post 10.11 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have commented on IQV. Jefferies Financial Group lowered shares of IQVIA from a “buy” rating to a “hold” rating and cut their price objective for the stock from $266.00 to $242.00 in a report on Wednesday. Barclays raised their price objective on IQVIA from $255.00 to $275.00 and gave the company an “overweight” rating in a research note on Tuesday. The Goldman Sachs Group assumed coverage on IQVIA in a research report on Thursday, June 6th. They issued a “buy” rating and a $270.00 target price on the stock. Morgan Stanley raised their price target on shares of IQVIA from $270.00 to $280.00 and gave the stock an “overweight” rating in a research report on Tuesday. Finally, Truist Financial increased their price objective on shares of IQVIA from $292.00 to $300.00 and gave the company a “buy” rating in a research note on Tuesday. Four investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, IQVIA presently has an average rating of “Moderate Buy” and an average target price of $263.56.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.